Market for Automatic Cell Imaging Systems: Global Insights, Trends, Size, Share, Outlook, and Opportunity Analysis, 2018-2026
The observation of living cells using time-lapse microscopy is known as live cell imaging or cell imaging (time-lapse photography applied to microscopy). In the study of cellular dynamics, scientists use cell imaging to gain a better knowledge of the biological operations of the body. The method was developed in the first half of the twentieth century. The development and fertilisation of a sea urchin egg were the subject of the first time-lapse microcinematographic videos. Since then, many microscopy techniques have been developed, allowing researchers to study living cells in more detail and with less effort. Quantum dots have been used to pioneer a new type of imaging.
In medical research, cell imaging has become an important technique. Automated microscopy and image analysis are used to investigate a wide range of topics, including the effect of chemical substances on cell development. Researchers in this field are especially interested in determining which substances, at what concentrations, capture the cell cycle or the time it takes to incubate. A cell's cell cycle is a set of phases that a cell goes through when it is dividing. If something goes wrong at any point during the transition from one phase to the next, the cell will go into programmed cell death. The research of these approaches necessitates complex image analysis workflows that might be mind-numbing.
The demand for an autonomous cell imaging system is increasing as the incidence of cancer rises at an alarming rate. Researchers are utilising an automatic cell imaging technology to analyse the division of cancer cells at the molecular level, in the hopes of finding a treatment for the fatal disease. This is anticipated to boost the market for automatic cell imaging systems as a whole.
Over the forecast period, the autonomous cell imaging system market is expected to grow due to the rising prevalence of cancer. According to the World Cancer Research Fund International (WCRFI), there were approximately 14.1 million cancer cases diagnosed worldwide in 2012, with around 7.4 million men and 6.6 million women affected. According to the WCRFI, there would be an increase of roughly 24 million cancer cases worldwide by 2035. Breast cancer, colon and rectum cancer, kidney and renal pelvis cancer, prostate cancer, non-Hodgkin lymphoma, leukaemia, thyroid cancer, lung and bronchus cancer, skin melanoma, bladder cancer, pancreatic cancer, and endometrial cancer were the most often diagnosed cancers.
The market is predicted to rise as product approvals and launches by key participants increase. For example, Molecular Devices, LLC announced the ImageXpress Pico Automated Cell Imaging System in February 2018, which automates manual tasks such as picture acquisition and post-processing and provides a user-friendly tool for study.
North America had the largest proportion of the global market for automatic cell imaging systems. The market is predicted to develop as the number of cancer cases in the region rises. According to the National Cancer Institute, 16.8 million new instances of cancer were diagnosed in the United States in 2016, with 595,690 people dying from the disease. By 2024, the number of cancer patients is predicted to reach 19 million. Furthermore, a survey published in the American Cancer Society's Cancer Journal for Clinicians estimates that roughly 1,735,350 new cancer cases would be diagnosed in the United States in 2018, with 87,290 instances of melanoma.
Favorable and constructive laws and regulations, as well as the availability of advanced healthcare facilities and increased governmental approvals for the use of automatic cell imaging systems, are expected to drive the automatic cell imaging system market in this area.
Comments
Post a Comment